Investors Sell Quintiles Transitional Holdings Inc. (Q) on Strength (Q)

Traders sold shares of Quintiles Transitional Holdings Inc. (NYSE:Q) on strength during trading on Tuesday. $21.36 million flowed into the stock on the tick-up and $62.53 million flowed out of the stock on the tick-down, for a money net flow of $41.17 million out of the stock. Of all equities tracked, Quintiles Transitional Holdings had the 24th highest net out-flow for the day. Quintiles Transitional Holdings traded up $0.41 for the day and closed at $96.20

Several research analysts have commented on the stock. BidaskClub downgraded shares of Quintiles Transitional Holdings from a “strong-buy” rating to a “buy” rating in a research report on Friday, August 11th. Jefferies Group LLC restated a “hold” rating and set a $94.00 price objective on shares of Quintiles Transitional Holdings in a research report on Friday, August 4th. Robert W. Baird restated a “hold” rating and set a $98.00 price objective on shares of Quintiles Transitional Holdings in a research report on Monday. Citigroup Inc. boosted their price objective on shares of Quintiles Transitional Holdings from $96.00 to $97.00 and gave the company a “neutral” rating in a research report on Monday, August 7th. Finally, William Blair upgraded shares of Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $70.10 to $93.42 in a report on Friday, August 4th. Eleven analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. Quintiles Transitional Holdings currently has an average rating of “Buy” and an average price target of $93.27.

The firm has a 50 day moving average of $95.52 and a 200 day moving average of $88.45. The firm has a market cap of $20.83 billion, a P/E ratio of 278.84 and a beta of 0.62.

Quintiles Transitional Holdings (NYSE:Q) last issued its earnings results on Thursday, August 3rd. The medical research company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. The company had revenue of $1.97 billion for the quarter, compared to analysts’ expectations of $1.96 billion. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. The firm’s revenue was up 68.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.93 EPS. Equities analysts forecast that Quintiles Transitional Holdings Inc. will post $4.58 EPS for the current year.

In related news, insider Kevin C. Knightly sold 20,000 shares of Quintiles Transitional Holdings stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $90.28, for a total value of $1,805,600.00. Following the transaction, the insider now owns 46,826 shares in the company, valued at approximately $4,227,451.28. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Kevin C. Knightly sold 19,339 shares of Quintiles Transitional Holdings stock in a transaction on Friday, August 25th. The stock was sold at an average price of $99.51, for a total transaction of $1,924,423.89. Following the completion of the transaction, the insider now owns 40,650 shares in the company, valued at approximately $4,045,081.50. The disclosure for this sale can be found here. In the last quarter, insiders sold 14,198,382 shares of company stock worth $1,361,834,375. 6.40% of the stock is owned by corporate insiders.

A number of large investors have recently modified their holdings of Q. Fiduciary Trust Co. purchased a new position in shares of Quintiles Transitional Holdings in the second quarter valued at about $105,000. Korea Investment CORP increased its position in shares of Quintiles Transitional Holdings by 142.5% in the second quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock valued at $123,000 after acquiring an additional 805 shares during the period. GWM Advisors LLC purchased a new position in shares of Quintiles Transitional Holdings in the second quarter valued at about $122,000. Global X Management Co. LLC increased its position in shares of Quintiles Transitional Holdings by 30.8% in the first quarter. Global X Management Co. LLC now owns 1,469 shares of the medical research company’s stock valued at $118,000 after acquiring an additional 346 shares during the period. Finally, Citigroup Inc. increased its position in shares of Quintiles Transitional Holdings by 15.5% in the second quarter. Citigroup Inc. now owns 1,858 shares of the medical research company’s stock valued at $167,000 after acquiring an additional 250 shares during t

Several research analysts have commented on the stock. BidaskClub downgraded shares of Quintiles Transitional Holdings from a “strong-buy” rating to a “buy” rating in a research report on Friday, August 11th. Jefferies Group LLC restated a “hold” rating and set a $94.00 price objective on shares of Quintiles Transitional Holdings in a research report on Friday, August 4th. Robert W. Baird restated a “hold” rating and set a $98.00 price objective on shares of Quintiles Transitional Holdings in a research report on Monday. Citigroup Inc. boosted their price objective on shares of Quintiles Transitional Holdings from $96.00 to $97.00 and gave the company a “neutral” rating in a research report on Monday, August 7th. Finally, William Blair upgraded shares of Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $70.10 to $93.42 in a report on Friday, August 4th. Eleven analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. Quintiles Transitional Holdings currently has an average rating of “Buy” and an average price target of $93.27.

The firm has a 50 day moving average of $95.52 and a 200 day moving average of $88.45. The firm has a market cap of $20.83 billion, a P/E ratio of 278.84 and a beta of 0.62.

Quintiles Transitional Holdings (NYSE:Q) last issued its earnings results on Thursday, August 3rd. The medical research company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. The company had revenue of $1.97 billion for the quarter, compared to analysts’ expectations of $1.96 billion. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. The firm’s revenue was up 68.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.93 EPS. Equities analysts forecast that Quintiles Transitional Holdings Inc. will post $4.58 EPS for the current year.

In related news, insider Kevin C. Knightly sold 20,000 shares of Quintiles Transitional Holdings stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $90.28, for a total value of $1,805,600.00. Following the transaction, the insider now owns 46,826 shares in the company, valued at approximately $4,227,451.28. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Kevin C. Knightly sold 19,339 shares of Quintiles Transitional Holdings stock in a transaction on Friday, August 25th. The stock was sold at an average price of $99.51, for a total transaction of $1,924,423.89. Following the completion of the transaction, the insider now owns 40,650 shares in the company, valued at approximately $4,045,081.50. The disclosure for this sale can be found here. In the last quarter, insiders sold 14,198,382 shares of company stock worth $1,361,834,375. 6.40% of the stock is owned by corporate insiders.

A number of large investors have recently modified their holdings of Q. Fiduciary Trust Co. purchased a new position in shares of Quintiles Transitional Holdings in the second quarter valued at about $105,000. Korea Investment CORP increased its position in shares of Quintiles Transitional Holdings by 142.5% in the second quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock valued at $123,000 after acquiring an additional 805 shares during the period. GWM Advisors LLC purchased a new position in shares of Quintiles Transitional Holdings in the second quarter valued at about $122,000. Global X Management Co. LLC increased its position in shares of Quintiles Transitional Holdings by 30.8% in the first quarter. Global X Management Co. LLC now owns 1,469 shares of the medical research company’s stock valued at $118,000 after acquiring an additional 346 shares during the period. Finally, Citigroup Inc. increased its position in shares of Quintiles Transitional Holdings by 15.5% in the second quarter. Citigroup Inc. now owns 1,858 shares of the medical research company’s stock valued at $167,000 after acquiring an additional 250 shares during the period. Institutional investors own 93.21% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright and trademark laws. The correct version of this news story can be read at https://ledgergazette.com/2017/10/10/investors-sell-quintiles-transitional-holdings-inc-q-on-strength-q.html.

About Quintiles Transitional Holdings

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply